Sex Hormones and Dream Frequency

Dreaming is a complex cognitive process predominantly associated with rapid eye movement (REM) sleep. While the neurophysiology of REM sleep is well-characterized, the factors modulating interindividual variability in dream recall frequency and vividness remain poorly understood. This theoretical review proposes a testable hypothesis: higher endogenous levels of sex hormones, specifically testosterone and estrogen, are associated with increased REM sleep activity, which in turn correlates with higher dream recall frequency and vividness. We synthesize evidence from neuroendocrinology and sleep medicine, outlining distinct and potentially synergistic roles of these hormones. Testosterone is associated with REM propensity via dopaminergic modulation of mesolimbic circuits, while estrogen correlates with REM enhancement through cholinergic facilitation and GABAergic disinhibition of brainstem REM-generating nuclei. Evidence from hormonal administration studies, menstrual cycle phases, and the menopausal transition supports these associations. The age-related decline in sex hormones parallels a reduction in REM density and dream recall, suggesting a link with cognitive aging and memory consolidation deficits. This framework positions dream recall frequency as a potential exploratory indicator of neuroendocrine health. We conclude by identifying critical research gaps and proposing a formal causal model with three testable predictions.